I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Advanced Retinal Imaging: How We Detect and Monitor Retinal Disease
What Is Retinal Imaging?
Retinal imaging is a group of diagnostic tests that allow a retina specialist to examine the detailed structures of your eye without surgery. Each technology offers a different type of information, and we often use several together to get a complete picture of your retinal health.
The retina lines the inside of the back of your eye and contains millions of light-sensitive cells called photoreceptors. These cells convert light into electrical signals that travel through the optic nerve to your brain, creating the images you see. Even small areas of retinal damage can have a meaningful impact on your vision.
Conditions like age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion (a blockage in the veins that supply blood to the retina) often cause no symptoms in their early stages. By the time vision changes become noticeable, significant damage may have already occurred. Imaging acts as an early warning system, revealing problems at a much more treatable stage.
Regular imaging also establishes a baseline. Every future scan is compared against your prior images, allowing us to track even subtle changes over time and adjust your care before problems become more serious.
Retinal imaging has advanced significantly over the past two decades. Older techniques relied on basic photographs and limited direct examination. Today, we have tools that create cross-sectional images of every retinal layer, map blood flow through the retinal vessels without dye injections, and capture the far edges of the retina in a single photograph. Some newer systems use artificial intelligence to help flag signs of disease automatically, making screening faster and more accessible than ever before.
Retinal Imaging Technologies We Use
Different imaging tests reveal different aspects of retinal health. Our specialists select the most appropriate combination of technologies based on each patient's condition, symptoms, and medical history.
OCT is one of the most widely used tools in retina care. It uses near-infrared light to produce detailed cross-sectional images of the retinal layers, similar to how an ultrasound uses sound waves to image tissue, but with far greater resolution. OCT can measure retinal thickness at a microscopic level and detect fluid buildup, swelling, and tissue thinning with exceptional precision.
This technology is essential for diagnosing and monitoring conditions such as AMD, diabetic macular edema (fluid that accumulates in the central retina due to diabetes), macular holes, and macular pucker (a wrinkling of the retinal surface that can distort central vision).
OCTA is a newer form of OCT that maps blood flow through the retinal vessels without requiring a dye injection. It works by detecting tiny differences between rapid repeated scans of the same area, identifying the movement of red blood cells through the vessels. The result is a detailed map of the retinal vascular network.
OCTA can reveal abnormal blood vessel growth, areas of poor circulation, and early vascular changes that are not visible on standard imaging. It is particularly helpful for monitoring wet AMD and diabetic retinopathy, and it is a valuable option for patients who cannot receive dye injections for medical reasons.
Fundus photography uses a specialized camera with a built-in low-power microscope to capture high-resolution color images of the retina. In many cases, we dilate your pupils with eye drops before this test to give the camera a clear, unobstructed view of the back of the eye.
These photographs create a permanent visual record of your retinal appearance at a specific point in time. By comparing images taken months or years apart, your retina specialist can identify changes that might not be apparent on examination alone. Fundus photography is routinely used to document and monitor diabetic retinopathy, AMD, and other retinal conditions.
Fluorescein angiography (FA) involves injecting a yellow dye called fluorescein into a vein in your arm. As the dye travels through your retinal blood vessels, a specialized camera captures a rapid series of photographs that highlight areas of leaking, blocked, or abnormal vessels. The test typically takes about 10 to 15 minutes.
FA remains an important tool for evaluating blood vessel problems in detail, particularly for wet AMD, diabetic retinopathy, and retinal vein occlusions. While OCTA can show vascular structure without dye, fluorescein angiography provides additional information about how vessels are functioning and exactly where leakage is occurring.
Standard retinal photographs capture only the central portion of the retina. Ultra-widefield imaging uses specialized equipment to photograph a much larger area, including the peripheral retina (the outer edges), in a single image. This broader view makes it possible to detect problems that standard photography might miss entirely.
Ultra-widefield imaging is particularly valuable for identifying peripheral retinal tears, areas of thinning, and blood vessel abnormalities associated with diabetic retinopathy, retinal detachment risk, and other conditions that affect regions beyond the center of the retina.
Fundus autofluorescence (FAF) captures the natural light emitted by a substance called lipofuscin, which accumulates in the retinal pigment epithelium (the supportive cell layer directly beneath the retina). Abnormal patterns of autofluorescence can reveal areas of cell stress, damage, or progressive breakdown.
FAF is especially useful for monitoring dry AMD and geographic atrophy, an advanced form of dry AMD where the retinal pigment epithelium deteriorates in expanding patches. It helps us understand which areas of the retina are healthy, at risk, or already compromised, and it plays a central role in tracking disease progression over time.
Advances in Retinal Imaging
The field of retinal imaging continues to evolve. Several newer technologies are expanding what we can detect, how we monitor patients between office visits, and how we support complex surgical care.
Artificial intelligence (AI) systems can now analyze retinal images and detect signs of disease automatically. The FDA has cleared several AI-powered systems for diabetic retinopathy screening, and these tools have demonstrated strong diagnostic accuracy in identifying patients who need further evaluation by a retina specialist.
AI screening systems can work with portable cameras and do not always require pupil dilation. They are designed to identify patients who need a referral, particularly in primary care and diabetes management settings where direct access to a retina specialist may be limited. AI is a screening aid, not a replacement for the clinical judgment of a trained retina specialist, who interprets imaging in the full context of your health history, symptoms, and examination findings.
Home-based OCT devices are an emerging development in retinal care. These systems allow patients with certain conditions, particularly wet AMD, to perform daily retinal scans at home. Results are transmitted to a retina specialist for remote review between scheduled office visits.
Home monitoring can detect early signs of disease activity, such as the return of fluid beneath the retina, sooner than a standard office visit schedule would allow. For some patients, this added information may help guide the timing of treatment more precisely.
Some advanced surgical suites now incorporate OCT imaging directly into the operating microscope. This technology, called intraoperative OCT, gives the surgeon real-time cross-sectional images of the retina during procedures such as vitrectomy (surgery to remove the gel-like fluid from inside the eye) and other complex retinal operations.
Intraoperative OCT allows surgeons to see tissue layers that are not visible through the microscope alone, improving precision and supporting better decision-making during surgery.
Adaptive optics technology, originally developed for use in astronomical telescopes, corrects for the natural optical imperfections of the human eye when applied to retinal cameras. The result is cellular-level resolution that allows individual photoreceptor cells to be visualized directly.
Adaptive optics imaging is currently used primarily in research settings. It holds promise for studying inherited retinal diseases and tracking the earliest cellular changes in conditions like AMD, potentially enabling earlier intervention as the technology matures and becomes more widely available.
Who Should Have Regular Retinal Imaging?
Retinal imaging is not only for patients who are already experiencing symptoms. Regular screening is recommended for anyone with risk factors for retinal disease, because catching changes early gives you the best opportunity to protect your vision.
Diabetes is one of the leading causes of vision loss in adults. Over time, elevated blood sugar damages the small blood vessels in the retina, leading to a condition called diabetic retinopathy. According to the National Eye Institute, diabetic retinopathy remains among the most common causes of blindness in working-age adults. Annual retinal imaging is recommended for all people with diabetes, even when no vision symptoms are present.
OCT is especially important for detecting diabetic macular edema, a complication where fluid accumulates in the central retina and can significantly blur central vision. Early detection through imaging allows treatment to begin before lasting damage occurs.
The risk of age-related macular degeneration rises significantly after age 50. According to the National Eye Institute, AMD affects nearly 20 million adults in the United States. Regular imaging with OCT and fundus autofluorescence can detect early signs of AMD before noticeable vision changes appear.
For patients with dry AMD, imaging tracks any progression toward geographic atrophy. For those who develop wet AMD, prompt detection is critical. Anti-VEGF treatment (medications injected into the eye to reduce abnormal blood vessel growth and fluid leakage) is most effective when started early, and wet AMD can progress rapidly if left untreated. It is important to note that anti-VEGF injections are a treatment for wet AMD and certain other vascular conditions, not for dry AMD.
High myopia, meaning severe nearsightedness, elongates the eye over time, which can thin and weaken the retina. People with high myopia face an increased risk of retinal tears, retinal detachment, and myopic macular degeneration, a condition where the central retina gradually thins due to the stretched shape of the eye.
Regular imaging can detect early thinning or tears in the peripheral retina before they develop into a detachment, which is a far more serious and urgent condition requiring immediate treatment.
If a close family member has AMD, diabetic retinopathy, or an inherited retinal condition such as retinitis pigmentosa (a group of genetic disorders that gradually damage the light-sensitive cells of the retina), your personal risk is higher than average. Genetic factors play a meaningful role in many retinal diseases, and a family history should prompt earlier and more regular screening.
Regular imaging provides an important baseline and gives us the ability to detect changes at the earliest possible stage, when treatment options are often most effective.
Several health and lifestyle factors make regular retinal monitoring especially important. These include:
- High blood pressure, which can damage the small blood vessels in the retina over time
- Smoking, which significantly raises the risk of AMD and other retinal conditions
- Cardiovascular disease, which is associated with changes in the retinal microvasculature
- Prolonged or unprotected exposure to ultraviolet light
- Poor dietary intake of nutrients that support retinal health, such as lutein and zeaxanthin
If any of these factors apply to you, speak with your retina specialist about the right imaging schedule for your individual situation.
What to Expect During a Retinal Imaging Appointment
Retinal imaging is generally painless and well-tolerated. Knowing what to expect ahead of time can help you feel at ease on the day of your visit.
Most imaging tests require little advance preparation. For some tests, we will place dilating eye drops in your eyes to widen the pupils. Dilation takes about 15 to 30 minutes to take full effect and causes temporary light sensitivity and blurred near vision that can last several hours. We recommend wearing sunglasses to your appointment and arranging for someone to drive you home afterward.
If your visit includes fluorescein angiography, please let us know in advance about any allergies, especially to dyes or medications. It is also helpful to mention any kidney problems or current medications you take, as these can affect how the dye is processed by your body.
Most imaging tests are non-invasive. You will sit comfortably in front of the imaging device and rest your chin on a support. Our technician will ask you to look in a specific direction and hold still for a few seconds while the device captures images. OCT scans typically take only a few minutes. Fluorescein angiography takes approximately 10 to 15 minutes.
You may notice a brief bright flash of light during some tests, but this should not be uncomfortable. If you receive fluorescein dye, your skin may appear slightly yellow for a day or two, and your urine may look bright yellow. Both effects are completely normal and temporary.
Results from most imaging tests are available right away. Your retina specialist can often review the images with you during the same visit and explain exactly what they show. All images become part of your permanent medical record and serve as a reference point for every future comparison.
If your pupils were dilated, please avoid driving until the effects have fully worn off. Most patients are able to return to their normal daily activities the same day.
Managing Your Retinal Health Over Time
Retinal imaging delivers the most value as an ongoing process, not a single event. Consistent monitoring allows us to detect changes early and respond before vision is meaningfully affected.
Your retina specialist will recommend an imaging schedule based on your specific condition and risk level. Patients with stable dry AMD may need imaging once or twice a year. Those receiving anti-VEGF injections for wet AMD or diabetic macular edema typically have an OCT scan at each treatment visit, because the results directly guide whether treatment is needed that day.
Keeping all scheduled imaging appointments is one of the most important steps you can take for your long-term eye health. Disease can progress between visits, and missed appointments can allow changes to go undetected until more significant damage has occurred.
Between appointments, simple tools like the Amsler grid can help you keep track of changes in your central vision. The Amsler grid is a chart of straight horizontal and vertical lines that you look at one eye at a time, wearing your reading glasses if you normally use them. If any lines appear wavy, bent, or missing, this may signal a change in your retina that needs prompt attention.
If your retina specialist recommends daily grid checks, make them part of your routine. Do not wait until your next scheduled visit if you notice a change. Report it right away, because some changes require urgent evaluation.
We encourage you to ask questions about your imaging results at every visit. Key findings to understand include your retinal thickness measurements, whether any fluid is present, and how your current images compare to your prior scans. Knowing what your results mean helps you stay informed about your condition and makes it easier to understand the reasoning behind your care plan.
Warning Signs That Require Prompt Attention
While routine imaging is essential, certain vision changes require urgent evaluation and should not wait for a scheduled appointment.
Contact a retina specialist right away, or go to an emergency room, if you experience any of the following:
- A sudden increase in floaters (spots, threads, or cobweb-like shapes drifting across your vision)
- New flashes of light, especially in your peripheral (side) vision
- A curtain, shadow, or dark area spreading across your visual field
- Sudden loss of vision in one eye
These symptoms can indicate a retinal tear or detachment, a retinal vein occlusion, or another serious condition. Prompt imaging and treatment may help prevent permanent vision loss.
Not all concerning changes happen suddenly. Schedule an appointment promptly if you notice any of the following developing over days or weeks:
- Wavy or distorted appearance of straight lines
- A dark, blurry, or missing spot in the center of your vision
- Increasing difficulty reading, even with your current glasses
- Trouble recognizing faces
- Gradual loss of side vision
These symptoms may indicate AMD, diabetic retinopathy, or other retinal conditions that benefit significantly from early evaluation and treatment.
Even without any symptoms, certain groups should have regular retinal imaging as a preventive measure. A dilated eye exam with imaging is recommended at least once a year for all people with diabetes. Adults over 50 should have imaging every one to two years, or more frequently if AMD has already been diagnosed. Anyone with a personal or family history of retinal disease should follow the monitoring schedule set by their retina specialist. Routine screening is the most reliable way to protect your vision over the long term.
Frequently Asked Questions
Here are answers to some of the questions we hear most often about retinal imaging. If you have additional questions, we are always glad to discuss them during your visit.
The large majority of retinal imaging tests are entirely non-invasive and use safe wavelengths of light rather than radiation. OCT, OCTA, fundus photography, and fundus autofluorescence carry no known risks. Fluorescein angiography, which involves a dye injection, carries a small possibility of mild nausea or, rarely, an allergic reaction. Serious reactions are uncommon. Before any test is performed, your retina specialist will review any relevant risks and answer your questions so you can make an informed decision.
The imaging itself is usually brief. An OCT scan takes around five minutes, fundus photography takes a few minutes per eye, and fluorescein angiography takes about 10 to 15 minutes. If your pupils need to be dilated beforehand, plan for an additional 15 to 30 minutes of waiting time before the test begins. Overall, most imaging appointments last between 30 and 60 minutes, depending on how many tests are needed and whether dilation is required.
Think of standard OCT as a structural scan. It produces cross-sectional images of the retinal layers, showing their thickness and detecting the presence of fluid, swelling, or tissue damage. OCTA adds blood flow information, mapping the retinal vessels in detail without requiring a dye injection. Your retina specialist may use both tests in combination: OCT tells us about the condition of the retinal tissue itself, while OCTA tells us about the vessels supplying it. Together, they provide a more complete picture than either test alone.
AI screening tools are designed to identify patients who may have disease and need further evaluation by a specialist, not to replace clinical expertise. FDA-cleared AI systems for diabetic retinopathy have shown strong screening accuracy and have expanded access to initial screening in primary care settings. However, AI does not account for your full medical history, current symptoms, or the individual nuances of your retinal anatomy. All imaging findings are interpreted by your retina specialist in the full context of your clinical picture, and all treatment decisions remain physician-directed based on your individual needs.
This depends on your condition and where you are in your treatment plan. Patients receiving anti-VEGF injections for wet AMD or diabetic macular edema typically have an OCT scan at each visit, because the results directly guide whether an injection is appropriate that day. Patients with stable conditions, such as early dry AMD, may only need imaging once or twice a year. Your retina specialist will set an imaging schedule tailored to your needs and may adjust it over time as your condition evolves.
Do not wait for your next scheduled visit. If you notice a sudden increase in floaters, new flashes of light, a shadow moving across your vision, or any change on your Amsler grid, contact our office the same day. For sudden, severe vision changes, treat the situation as an emergency and seek care immediately. Some retinal conditions, such as a retinal tear or vein occlusion, require prompt imaging and treatment to prevent irreversible damage, and time matters significantly in those situations.
Schedule Your Retinal Imaging Appointment
At New England Retina Associates, our fellowship-trained retina specialists use the full range of advanced imaging technologies to monitor and protect the vision of patients throughout Connecticut. Whether you have been referred by another eye care provider, are due for routine screening, or have noticed a change in your vision, we welcome you to schedule a visit at any of our four office locations. Early, accurate imaging is the foundation of the care we provide, and we are here to guide you through every step of understanding your results and your options.
30 Years of Care & Commitment
